Back to Search Start Over

Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder.

Authors :
Seo EH
Kim SG
Lee JH
Yoon HJ
Source :
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology [Clin Psychopharmacol Neurosci] 2023 Aug 31; Vol. 21 (3), pp. 604-608.
Publication Year :
2023

Abstract

Lamotrigine and aripiprazole have shown efficacy as augmentation agents of serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder (OCD). To date, the efficacy of lamotrigine/aripiprazole augmentation has not been reported in OCD treatment. Herein, we report the case of a 37-year-old male with severe OCD and comorbid depression whose symptoms markedly improved after low-dose lamotrigine/aripiprazole augmentation to clomipramine. Our report suggests that early glutamatergic/antipsychotic augmentation contributes to rapid remission of OCD symptoms.

Details

Language :
English
ISSN :
1738-1088
Volume :
21
Issue :
3
Database :
MEDLINE
Journal :
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
Publication Type :
Report
Accession number :
37424428
Full Text :
https://doi.org/10.9758/cpn.22.1044